Effects of Etomidate on Postoperative Circadian Rhythm Changes of Salivary Cortisol in Children

NCT ID: NCT02013986

Last Updated: 2013-12-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-09-30

Study Completion Date

2014-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Etomidate is an unique drug used for induction of general anesthesia and sedation. Adrenal cortical inhibition by etomidate has received much attention. However wether the circadian rhythm and pulse secretion pattern of cortisol in children are the same as that in adults is not known. Moreover, the effect of etomidate on circadian rhythm changes and clinical outcomes has never been carefully studied in children undergoing surgery. Our hypothesis is that etomidate can relieve the changes of circadian rhythm of salivary cortisol in children for 24-48 hours,and this does not make clinical outcomes worse postoperatively.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* Sample size assessment: Using formula to calculate the total number is 30.
* Statistical analysis: ANOVA
* Reporting for adverse events: During the period of study, if there is any severe adverse event happening, such as severe infection, severe low cortisol concentration threatening the patient's life we will stop the trial.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congenital Hydronephrosis Congenital Choledochal Cyst Fracture

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

etomidate salivary cortisol circadian rhythm children

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

etomidate & midazolam

a bolus of midazolam(Jiangsu Enhua Pharmaceutical Ltd.) 0.1mg/kg then a bolus of etomidate(Etomidate Fat Emulsion Injection, Jiangsu Enhua Pharmaceutical Ltd.)0.3 mg/kg and intravenously, during induction period, the other steps as usual.

Group Type EXPERIMENTAL

etomidate

Intervention Type DRUG

0.3mg/kg IV only once during induction of general anesthesia

midazolam

Intervention Type DRUG

midazolam 0.1mg/kg IV only once before using of etomidate/propofol during induction of general anesthesia

midazolam & propofol

During induction period,use a bolus of midazolam injection 0.1mg/kg(Jiangsu Enhua Pharmaceutical Ltd.) and then a bolus of propofol injection 2mg/kg(Astrazeneca PLC.)intravenously, the other steps are as usual.

Group Type ACTIVE_COMPARATOR

midazolam

Intervention Type DRUG

midazolam 0.1mg/kg IV only once before using of etomidate/propofol during induction of general anesthesia

propofol

Intervention Type DRUG

2mg/kg IV only once during induction of general anesthesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

etomidate

0.3mg/kg IV only once during induction of general anesthesia

Intervention Type DRUG

midazolam

midazolam 0.1mg/kg IV only once before using of etomidate/propofol during induction of general anesthesia

Intervention Type DRUG

propofol

2mg/kg IV only once during induction of general anesthesia

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Fuerli Liyuexi Diprivan

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 3-12 years old who are plan to undergo surgery

Exclusion Criteria

* endocrine disease, blood infusion, having fever, ulcer or bleeding in the oral cavity
Minimum Eligible Age

3 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Du yi

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Du yi

attending of anesthesiology

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wng Y Wei, professor

Role: STUDY_DIRECTOR

Shanghai Jiao Tong University School of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

department of anesthesia of Xinhua Hospital

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Chen yijun

Role: CONTACT

Phone: 86-21-13764206966

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Wang Yinwei

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

X01PA131001

Identifier Type: -

Identifier Source: org_study_id